Abstract | BACKGROUND: METHODS AND RESULTS: Patients with essential hypertension and echocardiographically diagnosed LVH were included in a double-blind study to receive treatment with either the angiotensin II type 1 receptor (AT1-receptor) antagonist irbesartan (n = 41), or the beta-1 adrenergic receptor blocker atenolol (n = 43) as monotherapy for 3 months. The angiotensinogen T174M and M235T, the angiotensin-converting enzyme I/D, the AT1-receptor A1166C and the aldosterone synthase ( CYP11B2) -344 C/T polymorphisms were analysed and related to the change in left ventricular mass (LVM). Patients with the angiotensinogen 174 TM genotype treated with irbesartan responded with the greatest reduction in LVM (-23 +/- 31SD g/m2 for TM and +0.5 +/- 18 g/m2 for TT, P = 0.005), independent of blood pressure reduction. Both the angiotensinogen 235 T-allele (P = 0.02) and the AT1-receptor 1166 AC genotype responded with the greatest reduction in LVM when treated with irbesartan (-0.1 +/- 19 g/m2 for AA and -18 +/- 30 g/m2 for AC, P = 0.02), independent of blood pressure reduction. These polymorphisms were not associated with the change in LVM during treatment with atenolol. DISCUSSION:
|
Authors | Lisa Kurland, Håkan Melhus, Julia Karlsson, Thomas Kahan, Karin Malmqvist, Peter Ohman, Fredrik Nyström, Anders Hägg, Lars Lind |
Journal | Journal of hypertension
(J Hypertens)
Vol. 20
Issue 4
Pg. 657-63
(Apr 2002)
ISSN: 0263-6352 [Print] England |
PMID | 11910301
(Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Angiotensin Receptor Antagonists
- Antihypertensive Agents
- Biphenyl Compounds
- Receptor, Angiotensin, Type 1
- Receptors, Angiotensin
- Tetrazoles
- Angiotensinogen
- Atenolol
- Irbesartan
|
Topics |
- Aged
- Alleles
- Angiotensin Receptor Antagonists
- Angiotensinogen
(genetics)
- Antihypertensive Agents
(therapeutic use)
- Atenolol
(therapeutic use)
- Biphenyl Compounds
(therapeutic use)
- Female
- Humans
- Hypertension
(drug therapy, genetics, pathology)
- Hypertrophy, Left Ventricular
(drug therapy, genetics, pathology)
- Irbesartan
- Male
- Middle Aged
- Polymorphism, Genetic
- Receptor, Angiotensin, Type 1
- Receptors, Angiotensin
(genetics)
- Renin-Angiotensin System
(genetics)
- Sweden
- Tetrazoles
(therapeutic use)
|